Literature DB >> 6872596

Respiratory muscle dysfunction in systemic lupus erythematosus.

J Martens, M Demedts, M T Vanmeenen, J Dequeker.   

Abstract

An assessment of pulmonary mechanics revealed weakness of inspiratory and expiratory muscles as cause of the restrictive ventilatory defect (vital capacity: 47 +/- 10 percent predicted) in seven (ages 33 to 62 years) out of 26 consecutive patients with systemic lupus erythematosus (SLE). Maximal inspiratory transdiaphragmatic pressures were reduced mainly due to the markedly increased (more positive) esophageal pressures. During maximal expiratory efforts, esophageal and gastric pressures were grossly decreased. These abnormalities probably may be considered part of a more generalized, yet subclinical muscle disorder due to the SLE with, however, predominant involvement of the respiratory muscles. The abnormalities were not related to the use of corticosteroids or generalized inanition. The static expiratory lung compliance was reduced in all patients (55 +/- 18 percent predicted), but normalized immediately following passive inflation of the lungs to transpulmonary pressures of more than 30 cm H2O in two of the three subjects tested. The volume restriction was not progressive over a period of 38.5 patient-years.

Entities:  

Mesh:

Year:  1983        PMID: 6872596     DOI: 10.1378/chest.84.2.170

Source DB:  PubMed          Journal:  Chest        ISSN: 0012-3692            Impact factor:   9.410


  7 in total

Review 1.  Imaging of the pulmonary manifestations of systemic disease.

Authors:  A G Rockall; D Rickards; P J Shaw
Journal:  Postgrad Med J       Date:  2001-10       Impact factor: 2.401

Review 2.  Diaphragmatic paresis: pathophysiology, clinical features, and investigation.

Authors:  G J Gibson
Journal:  Thorax       Date:  1989-11       Impact factor: 9.139

3.  The "shrinking lung syndrome" in SLE, treatment with theophylline.

Authors:  S Van Veen; A J Peeters; P J Sterk; F C Breedveld
Journal:  Clin Rheumatol       Date:  1993-12       Impact factor: 2.980

4.  Respiratory disease in systemic lupus erythematosus: correlation with results of laboratory tests and histological appearance of muscle biopsy specimens.

Authors:  S A Evans; N D Hopkinson; W J Kinnear; L Watson; R J Powell; I D Johnston
Journal:  Thorax       Date:  1992-11       Impact factor: 9.139

Review 5.  Shrinking lung syndrome masked by pleuropericarditis: a case report and review of the literature.

Authors:  Iman Hemmati; Kenneth Blocka
Journal:  Clin Rheumatol       Date:  2012-08-26       Impact factor: 2.980

6.  Respiratory tract disease in systemic lupus erythematosus.

Authors:  J C de Jongste; H J Neijens; E J Duiverman; J M Bogaard; K F Kerrebijn
Journal:  Arch Dis Child       Date:  1986-05       Impact factor: 3.791

Review 7.  Shrinking lung syndrome in systemic lupus erythematosus: A case series and review of the literature.

Authors:  Helena Borrell; Javier Narváez; Juan José Alegre; Ivan Castellví; Francesca Mitjavila; María Aparicio; Eulàlia Armengol; María Molina-Molina; Joan M Nolla
Journal:  Medicine (Baltimore)       Date:  2016-08       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.